| Literature DB >> 29207449 |
Seon-Ha Kim1, Min-Woo Jo1, Minsu Ock1, Sang-Il Lee1.
Abstract
OBJECTIVES: This study aimed to explore dimensions in addition to the 5 dimensions of the 5-level EQ-5D version (EQ-5D-5L) that could satisfactorily explain variation in health-related quality of life (HRQoL) in the general population of South Korea.Entities:
Keywords: Patient outcomes assessment; Quality of life; Self-report; Surveys and questionnaires; Visual analog scale
Mesh:
Year: 2017 PMID: 29207449 PMCID: PMC5717327 DOI: 10.3961/jpmph.16.076
Source DB: PubMed Journal: J Prev Med Public Health ISSN: 1975-8375
Socio-demographic characteristics and self-rated health of the study participants
| Variable | n (%) | EQ-VAS (mean±SD) |
|---|---|---|
| Sex[ | ||
| Male | 296 (49.3) | 80.6±12.5 |
| Female | 304 (50.7) | 78.3±15.3 |
| Age (y) | ||
| 20-29 | 98 (16.3) | 83.0±14.1 |
| 30-39 | 125 (20.8) | 80.3±11.4 |
| 40-49 | 134 (22.3) | 80.5±13.0 |
| 50-59 | 117 (19.5) | 80.0±14.2 |
| 60+ | 126 (21.0) | 74.1±15.9 |
| Education level[ | ||
| Elementary school or below | 47 (7.8) | 69.7±17.5 |
| Middle school | 70 (11.7) | 73.9±16.7 |
| High school | 270 (45.0) | 80.6±13.4 |
| College or above | 213 (35.5) | 81.8±11.6 |
| Ambulatory care visit in the past 2 wk[ | ||
| Yes | 118 (19.7) | 72.9±16.7 |
| No | 482 (80.3) | 81.0±12.9 |
| Hospitalization in the past 12 mo[ | ||
| Yes | 61 (10.2) | 73.5±17.8 |
| No | 539 (89.8) | 80.1±13.4 |
| Morbidity[ | ||
| Yes | 145 (24.2) | 73.5±16.9 |
| No | 455 (75.8) | 81.3±12.4 |
| Self-rated health[ | ||
| Very good | 118 (19.7) | 88.9±10.5 |
| Good | 317 (52.8) | 81.5±10.1 |
| Moderate | 131 (21.8) | 72.1±13.0 |
| Bad | 32 (5.3) | 57.2±18.4 |
| Very bad | 2 (0.3) | 25.0±7.1 |
EQ, EuroQol; VAS, visual analogue scale; SD, standard deviation.
p<0.05,
p<0.01 by Student t-test or analysis of variance.
Problems reported in the 12 dimensions and the corresponding EQ-VAS scores
| Level[ | n (%) | EQ-VAS (mean±SD)[ | |
|---|---|---|---|
| EQ-5D dimensions | |||
| Mobility | 1 | 531 (88.5) | 81.3±12.4 |
| 2 | 51 (8.5) | 65.2±15.7 | |
| 3 | 10 (1.7) | 77.2±14.8 | |
| 4 | 7 (1.2) | 45.7±16.4 | |
| 5 | 1 (0.2) | 60.0 (N/A) | |
| Self-care | 1 | 576 (96.0) | 80.3±13.3 |
| 2 | 16 (2.7) | 61.9±15.3 | |
| 3 | 5 (0.8) | 47.0±17.9 | |
| 4 | 1 (0.2) | 55.0 (N/A) | |
| 5 | 2 (0.3) | 70.0±14.1 | |
| Usual activities | 1 | 547 (91.2) | 81.1±12.3 |
| 2 | 43 (7.2) | 64.4±17.8 | |
| 3 | 5 (0.8) | 58.0±13.0 | |
| 4 | 4 (0.7) | 38.8 ±16.5 | |
| 5 | 1 (0.2) | 60.0 (N/A) | |
| Pain/discomfort | 1 | 436 (72.7) | 82.1±11.8 |
| 2 | 134 (22.3) | 74.4±15.4 | |
| 3 | 20 (3.3) | 69.6±17.7 | |
| 4 | 9 (1.5) | 51.7±17.5 | |
| 5 | 1 (0.2) | 30.0 (N/A) | |
| Anxiety/depression | 1 | 456 (76) | 81.8±12.2 |
| 2 | 125 (20.8) | 74.7±13.3 | |
| 3 | 13 (2.2) | 60.0±16.5 | |
| 4 | 5 (0.8) | 28.0±23.6 | |
| 5 | 0 (0.0) | N/A | |
| Additional dimensions | |||
| Vision | 1 | 482 (80.3) | 81.3±12.8 |
| 2 | 93 (15.5) | 73.9±13.7 | |
| 3 | 23 (3.8) | 63.7±22.7 | |
| 4 | 2 (0.3) | 70.0±14.1 | |
| 5 | 0 (0.0) | N/A | |
| Hearing | 1 | 547 (91.2) | 80.6±13.3 |
| 2 | 42 (7.0) | 70.2±13.6 | |
| 3 | 5 (0.8) | 46.0±20.7 | |
| 4 | 5 (0.8) | 57.0±8.4 | |
| 5 | 1 (0.2) | 80.0 (N/A) | |
| Communication | 1 | 563 (93.8) | 80.3±13.6 |
| 2 | 29 (4.8) | 67.9±13.7 | |
| 3 | 5 (0.8) | 55.0±10.0 | |
| 4 | 2 (0.3) | 52.5±3.5 | |
| 5 | 1 (0.2) | 70.0 (N/A) | |
| Cognitive function[ | 1 | 506 (84.3) | 81.0±13.1 |
| 2 | 79 (13.2) | 71.1±16.1 | |
| 3 | 12 (2.0) | 68.3±11.1 | |
| 4 | 2 (0.3) | 52.5±3.5 | |
| 5 | 1 (0.2) | 99.0 (N/A) | |
| Social relationships | 1 | 487 (81.2) | 81.0±13.1 |
| 2 | 90 (15.0) | 75.1±12.4 | |
| 3 | 19 (3.2) | 68.2±20.4 | |
| 4 | 4 (0.7) | 40.0±24.2 | |
| 5 | 0 (0.0) | N/A | |
| Vitality | 1 | 380 (63.3) | 83.2±11.2 |
| 2 | 181 (30.2) | 74.9±14.6 | |
| 3 | 33 (5.5) | 67.6±14.6 | |
| 4 | 5 (0.8) | 41.0±20.4 | |
| 5 | 1 (0.2) | 30.0 (N/A) | |
| Sleep | 1 | 449 (74.8) | 81.9±12.2 |
| 2 | 113 (18.8) | 74.6 (13.9) | |
| 3 | 26 (4.3) | 64.2±23.1 | |
| 4 | 11 (1.8) | 62.7±15.7 | |
| 5 | 1 (0.2) | 70.0 (N/A) |
EQ, EuroQol; VAS, visual analogue scale; SD, standard deviation; N/A, not applicable.
Level: 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, extreme problems or unable to do.
One response was missing.
p<0.05 by analysis of variance.
Analysis of the ceiling effect of the EQ-5D-5L and the 12 dimensions used in this study
| Problems reported by full-health respondents on the EQ-5D (n = 365) | Problems reported by full-health respondents on all 12 dimensions (n=249) | |
|---|---|---|
| Vitality | 68 (18.6) | - |
| Sleep | 38 (10.4) | - |
| Vision | 30 (8.2) | - |
| Social relationships | 30 (8.2) | - |
| Cognitive function | 14 (3.8) | - |
| Hearing | 10 (2.7) | - |
| Communication | 5 (1.4) | - |
| Ambulatory visit in past 2 wk | 37 (10.1) | 24 (9.6) |
| Hospitalization in past 12 mo | 27 (7.4) | 14 (5.6) |
| Current disease | 49 (13.4) | 21 (8.4) |
| Self-rated health (moderate to very bad) | 52 (14.3) | 28 (11.2) |
Values are presented as number (%).
EQ-5D-5L, 5-level EQ-5D version; EQ-5D, EuroQol-5D.
Linear regression analysis for the independent contributions of health problems in the EQ-VAS dimensions
| Model A | Model B | Model C | |
|---|---|---|---|
| EQ-5D dimensions | |||
| Mobility | -7.02 (-11.25, -2.80)[ | - | -5.18 (-9.61, -0.74)[ |
| Self-care | -3.16 (-9.47, 3.15) | - | -1.72 (-8.37, 4.93) |
| Usual activities | -9.65 (-14.31, -4.98)[ | - | -8.46 (-13.11, -3.81)[ |
| Pain/discomfort | -2.72 (-5.45, 0.01) | - | -1.41 (-4.21, 1.39) |
| Anxiety/depression | -5.61 (-8.23, -3.00)[ | - | -3.28 (-6.03, -0.53)[ |
| Additional dimensions | |||
| Vision | - | -2.88 (-5.88, 0.12) | -0.82 (-3.82, 2.17) |
| Hearing | - | -5.31 (-10.37, -0.25)[ | -2.83 (-7.84, 2.19) |
| Communication | - | -1.31 (-7.32, 4.71) | 0.43 (-5.61, 6.47) |
| Cognitive function | - | -2.12 (-5.72, 1.47) | 0.33 (-3.23, 3.89) |
| Social relationships | - | -0.79 (-3.87, 2.30) | 0.12 (-2.90, 3.14) |
| Vitality | - | -6.19 (-8.71, -3.67)[ | -4.08 (-6.62, -1.55)[ |
| Sleep | - | -4.90 (-7.52, -2.28)[ | -3.41 (-6.01, -0.81)[ |
| R2 | 0.228 | 0.200 | 0.263 |
Values are presented as β (95% confidence interval).
EQ, EuroQol; VAS, visual analogue scale; EQ-5D, EuroQol-5D.
p<0.05,
p<0.01.